Noven Files Patent Infringement Lawsuit against Watson Pharmaceuticals - MarketWatch

Noven Pharmaceuticals, Inc. announced today that it has filed a lawsuit in the U.S. District Court of New Jersey against Watson Pharmaceuticals ("Watson") for infringement of certain Noven patents (the "Patents") by Watson. The lawsuit was filed as a result of an Abbreviated New Drug Application (ANDA) submission by Watson seeking FDA approval to market and sell a generic version of Daytrana(R) (methylphenidate transdermal system)...